Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 8/20 | 0.60 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.60 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.60 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.60 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.60 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.60 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.60 |
| ▸ | HTR1A | P08908 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | PGR | P06401 | 1/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.60 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.60 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.60 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.60 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28778365 | 0.98 | CHRM1 (0.61) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL26035455 | 0.86 | CHRM1 (0.45) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL3780770 | 0.84 | CHRM1 (0.58) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL2359243 | 0.82 | CHRM1 (0.59) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Water SCHEMBL12506247 | 0.82 | CHRM1 (0.56) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL13376408 | 0.81 | FABP3 (0.46) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL188001 | 0.81 | CHRM1 (0.60) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL31591104 | 0.81 | CHRM1 (0.60) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL12023250 | 0.80 | CHRM1 (0.54) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL18719945 | 0.80 | CHRM1 (0.39) | CHRM1CHRM3CHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802207-B2 | Melt extrusion of hemp-based thermoplastics | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-10-31 | — | — | US | claimed |
| WO-2022147330-A1 | MELT EXTRUSION OF HEMP-BASED THERMOPLASTICS | NORTH CAROLINA STATE UNIVERSITY (US) | 2022-07-07 | — | — | WO | claimed |
| US-20220204774-A1 | MELT EXTRUSION OF HEMP-BASED THERMOPLASTICS | NORTH CAROLINA STATE UNIVERSITY | 2022-06-30 | — | — | US | claimed |
| EP-3129116-A1 | CONTAMINATION MITIGATION | Butamax Advanced Biofuels LLC (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157607-A1 | CONTAMINATION MITIGATION | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-10-15 | — | — | WO | claimed |
| US-20250341031-A1 | MELT SPINNING LIGNIN/ACRYLIC FIBERS | NORTH CAROLINA STATE UNIVERSITY (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250243607-A1 | MELT SPINNING OF BLENDED CELLULOSE ACETATE BUTYRATE FIBERS | NORTH CAROLINA STATE UNIVERSITY (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250223731-A1 | MELT SPINNING OF BLENDED POLYLACTIC ACID FIBERS | NORTH CAROLINA STATE UNIVERSITY (US) | 2025-07-10 | — | — | US | disclosed |
| EP-4483004-A2 | MELT SPINNING OF BLENDED POLYLACTIC ACID FIBERS | North Carolina State University (US) | 2025-01-01 | — | — | EP | disclosed |
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VECTIVBIO COMET AG (CH) | 2024-07-16 | — | — | US | disclosed |
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VECTIVBIO COMET AG (CH) | 2024-07-16 | — | — | US | disclosed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20120171262-A1 | PHARMACEUTICAL FORMULATIONS | ABBVIE INC. | 2012-07-05 | — | — | US | disclosed |
| WO-2012023629-A1 | LIQUID COMPOSITION, RECORDING METHOD, AND RECORDED MATTER | RICOH COMPANY, LTD. (JP) | 2012-02-23 | — | — | WO | disclosed |
| US-20110243939-A1 | MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS | PSIOXUS THERAPEUTICS LIMITED (GB) | 2011-10-06 | — | — | US | disclosed |
| US-7402690-B2 | Chain transfer agents for raft polymerization in aqueous media | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2008-07-22 | — | — | US | disclosed |
| US-20070123670-A1 | Chain transfer agents for raft polymerization in aqueous media | MCCORMICK CHARLES L | 2007-05-31 | — | — | US | disclosed |
| US-20060280790-A1 | Pharmaceutical formulations | FOURNIER LABORATORIES IRELAND LTD (IE) | 2006-12-14 | — | — | US | disclosed |
| CN-1854120-A | Non-toxic ion liquid its production and use | UNIV HEBEI NORMAL (CN) | 2006-11-01 | — | — | CN | disclosed |
| CN-1651089-A | Nontoxic ionic liquid, preparation method and application thereof | UNIV HEBEI NORMAL (CN) | 2005-08-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | AHR, ARNT, HCAR1 | CHRM1 1232/4885CHRM3 374/4885CHRM2 1067/4885 |
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VNN1, VKORC1, PANK3 | CHRM1 4006/4885CHRM3 3530/4885CHRM2 3325/4885 |
| US-20110243939-A1 | MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS | POLL, POLI, POLR2H | CHRM1 4297/4885CHRM3 4533/4885CHRM2 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.